BM TRINITAS PHARMA LIMITED
BM TRINITAS PHARMA LIMITED is a private limited company registered in the United Kingdom, under 14759446, incorporated on 27 March 2023. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 3 years. Registered office address: WC2H 9JQ London, the United Kingdom. Directors include MR PAUL JONATHAN BALLINGTON, MR BRETT MOONEY, and MR STEPHEN RAYMOND SELF. Shareholders include MR STEPHEN RAYMOND SELF and MR BRETT MOONEY, and 1 other. Associated with 2 related entities, including TRINITAS PHARMA CONSULTING LIMITED and STREAM BIO LTD. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Registered Address
71-75 SHELTON STREET
COVENT GARDEN
WC2H 9JQ LONDON
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Change Log (1)
| Date | Change | Details |
|---|---|---|
| 2026-04-11 | DIRECTOR ADDED | Paul Jonathan Ballington (director) |
Source Records (1)
| companieshouse | 14759446 | 2026-06-01 | open_in_new |